• Accueil >
  • Publications >
  • Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

1 janv. 2019Breast Cancer Research and Treatment

DOI : 10.1007/s10549-018-5017-2

Auteurs

Luc Cabel, Matthieu Carton, Bianca Cheaib, Jean-Yves Pierga, Florence Dalenc, Audrey Mailliez, Christelle Levy, William Jacot, Marc Debled, Marianne Leheurteur, Isabelle Desmoulins, Claudia Lefeuvre, Anthony Gonçalves, Lionel Uwer, Jean-Marc Ferrero, Jean-Christophe Eymard, Thierry Petit, Marie-Ange Mouret-Reynier, Geneviève Perrocheau, Irwin Piot, David Pérol, Gaëtane Simon, Florence Lerebours